TMCnet News
ZetrOZ Systems Partners With the National Institute on AgingTRUMBULL, Conn., April 15, 2021 /PRNewswire/ -- Through support from the National Institute on Aging, ZetrOZ Systems, developers of the Sustained Acoustic Medicine (sam®) wearable ultrasound, is expanding the research pipeline of non-surgical, non-opioid treatment options. "With support from the National Institute on Aging, we are better able to develop our sam® product lines in hopes of being able to help people live better, longer, without the risk of addiction or the challenges of recovering from intensive surgeries," said Dr. George Lewis, founder and chief executive officer of ZetrOZ Systems. The National Institute on Aging (NIA), one of the 27 Institutes and Centers of the National Institutes of Health (NIH), has supported ZetrOZ and its sam® technology since 2019 as part of its ongoing mission to understand the nature of aging and to extend the healthy, active years of life. Through their partnership, the NIA will continue to advocate for the use of sam® to improve the lives and wellbeing of patients suffering from physical pain related to aging. In addition, the NIA has invested research capital to help mature many of ZetrOZ's product offerings and further support their product portfolio through the development and discovery of effective combination therapies. "sam®'s ability to provide targeted and localized therapy combined with topical NSAIDs (nonsteroidal anti-inflammatory drugs) is the ideal solution for older patients who aren't suitable candidates for surgery, or are already on several medications and don't want or need to be taking any more pills," Lewis said. The NIA supports ZetrOZ through:
To learn more about ZetrOZ and its sam® line of products, visit samrecover.com. About ZetrOZ Systems: Media Contact: Related Images View original content to download multimedia:http://www.prnewswire.com/news-releases/zetroz-systems-partners-with-the-national-institute-on-aging-301269543.html SOURCE ZetrOZ Systems |